StockData
Thermo Fisher Scientific Inc. logo

Thermo Fisher Scientific Inc.

TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 12/3027% above fair value
$682.65−14.35 (-2.06%)

Close on Nov 2, 2026Market cap $252.41BP/E 36.0Yield 0.25%

Thermo Fisher Scientific Specialty Diagnostics Segment by Quarter

Specialty Diagnostics Segment (Total Segment Revenue) ($M)

QuarterlyAnnual

Thermo Fisher Scientific Specialty Diagnostics Segment: $1,098M in Q3 2026, down 6.5% from a year earlier.

Latest, Q3 2026
1,098
Period ended Sep 30, 2026
Change on a year earlier
-6.5%
1,174 in Q3 2025
History
19 quarters
Since Q1 2022
Sources
7
Documents cited below

Where the Q3 2026 figure comes from

“SD: Revenues 1,148 1,134 1,174 1,220 4,676 1,142 1,205 1,098”

Source: Q3 2026 Reconciliation of Financial Information ↗

Includes 5 operating businesses specializing in medical diagnostics.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedSpecialty Diagnostics Segment (Total Segment Revenue) ($M)Year on yearSource
Q3 2026Sep 30, 20261,098-6.5%Q3 2026 Reconciliation of Financial Information ↗
Q2 2026Jun 30, 20261,205+6.3%Q3 2026 Reconciliation of Financial Information ↗
Q1 2026Mar 31, 20261,142-0.5%Q3 2026 Reconciliation of Financial Information ↗
Q4 2025Dec 31, 20251,220+5.4%Q3 2026 Reconciliation of Financial Information ↗
Q3 2025Sep 30, 20251,174+4.0%Q3 2026 Reconciliation of Financial Information ↗
Q2 2025Jun 30, 20251,134+1.5%Q3 2026 Reconciliation of Financial Information ↗
Q1 2025Mar 31, 20251,148+3.5%Q3 2026 Reconciliation of Financial Information ↗
Q4 2024Dec 31, 20241,157+4.7%Q4 & FY2025 Reconciliation of Financial Information ↗
Q3 2024Sep 30, 20241,129+4.2%Q4 & FY2025 Reconciliation of Financial Information ↗
Q2 2024Jun 30, 20241,117+0.7%Q4 & FY2025 Reconciliation of Financial Information ↗
Q1 2024Mar 31, 20241,109+0.1%Q4 & FY2025 Reconciliation of Financial Information ↗
Q4 2023Dec 31, 20231,105-0.9%Q4 & FY2024 Reconciliation of Financial Information ↗
Q3 2023Sep 30, 20231,083+1.7%Q4 & FY2024 Reconciliation of Financial Information ↗
Q2 2023Jun 30, 20231,109+0.7%Q4 & FY2024 Reconciliation of Financial Information ↗
Q1 2023Mar 31, 20231,108-25.2%Q4 & FY2024 Reconciliation of Financial Information ↗
Q4 2022Dec 31, 20221,115–SEC Form 8-K (8k_2023Q4, filed 2024-01-31) ↗

Breakdown

What makes up specialty Diagnostics Segment

Cite this data

StockData. (2026). Thermo Fisher Scientific Specialty Diagnostics Segment ($M), quarterly Q1 2022–Q3 2026 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/rev-seg-sd

See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.